These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6665561)

  • 1. Selection of participants for clinical trials in cancer prevention.
    Horton J
    Semin Oncol; 1983 Sep; 10(3):348-54. PubMed ID: 6665561
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
    DeWys WD; Greenwald P
    Semin Oncol; 1983 Sep; 10(3):360-4. PubMed ID: 6665563
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trend toward noninferiority trials may mean more difficult interpretation of trial results.
    Tuma RS
    J Natl Cancer Inst; 2007 Dec; 99(23):1746-8. PubMed ID: 18042926
    [No Abstract]   [Full Text] [Related]  

  • 5. Recruiting participants to cancer prevention clinical trials: lessons from successful community oncology networks.
    McKinney MM; Weiner BJ; Wang V
    Oncol Nurs Forum; 2006 Sep; 33(5):951-9. PubMed ID: 16955123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The convergence of cancer prevention and therapy in early-phase clinical drug development.
    Abbruzzese JL; Lippman SM
    Cancer Cell; 2004 Oct; 6(4):321-6. PubMed ID: 15488755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer chemoprevention.
    Hong WK; Lippman SM
    J Natl Cancer Inst Monogr; 1995; (17):49-53. PubMed ID: 8573453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enrichment designs: efficiency in development of cancer treatments.
    Temple RJ
    J Clin Oncol; 2005 Aug; 23(22):4838-9. PubMed ID: 15983397
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlled prophylactic trials in cancer.
    Magnus K; Miller AB
    J Natl Cancer Inst; 1980 Apr; 64(4):693-9. PubMed ID: 6928983
    [No Abstract]   [Full Text] [Related]  

  • 10. Vitamin C as a cancer treatment: state of the science and recommendations for research.
    Tamayo C; Richardson MA
    Altern Ther Health Med; 2003; 9(3):94-101. PubMed ID: 12776480
    [No Abstract]   [Full Text] [Related]  

  • 11. The convergent development of molecular-targeted drugs for cancer treatment and prevention.
    Lippman SM; Heymach JV
    Clin Cancer Res; 2007 Jul; 13(14):4035-41. PubMed ID: 17634526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer prevention clinical trials.
    Greenwald P
    J Clin Oncol; 2002 Sep; 20(18 Suppl):14S-22S. PubMed ID: 12235220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How can we improve clinical trials?
    Kaplan RS
    Nat Clin Pract Oncol; 2007 Apr; 4(4):206-7. PubMed ID: 17392712
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemoprevention of cancers].
    Espie M
    Bull Cancer; 1995 Jul; 82 Suppl 3():181s-185s. PubMed ID: 7492832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethics and chemoprevention research.
    Weed DL
    Semin Oncol; 1983 Sep; 10(3):355-9. PubMed ID: 6665562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials of parenteral antineoplastic agents.
    Cusack G
    J Intraven Nurs; 1998; 21(6):339-43. PubMed ID: 10392099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translating knowledge generated by epidemiological and in vitro studies into dietary cancer prevention.
    Jeffery EH; Keck AS
    Mol Nutr Food Res; 2008 Jun; 52 Suppl 1():S7-17. PubMed ID: 18327874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are clinical trials the "gold standard" for cancer prevention research?
    Kristal AR
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3289-91. PubMed ID: 19064540
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.
    Suman VJ; Dueck A; Sargent DJ
    Cancer Invest; 2008 Jun; 26(5):439-44. PubMed ID: 18568764
    [No Abstract]   [Full Text] [Related]  

  • 20. An evidence-based approach to cancer prevention clinical trials.
    Greenwald P; McDonald SS; Anderson DE
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S43-7. PubMed ID: 12570334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.